Objectives: To determine the prevalence of metabolic syndrome (MS) in patients with gout, and study its manifestations depending on the nature of renal disease. Materials and methods: 365 patients with gout have been examined: 310 with chronic gout, 55 with acute gout. Age from 18 to 81 years old. Disease duration was between 1 and 42 years. Results and discussion: Joint involvement: the first MTP joint – 298 (81,6%), by ankle joints in 186 (50,9%), knee joints in 159 (43,5%), the joints of the upper limbs – 119 (32,6%) patients. Kidney involvement – 174 (47,7%) patients had tubular‑interstitial nephritis with uric acid diathesis, 162 (44,4%) patients had nephrolithiasis. MS was diagnosed in 189 (51,8%) patients with gout, a Waist Circumference of > 94 cm was seen in 189 (51,8%), triglycerides> 1.7mmol/l in 178 (48,8%), glucose> 6.1 mmol/l in 161 (44,1%) patients. Decreased glomerular filtration rate below 60 ml/min – 164 (44,9%) of gout patients with MS, 48 (13,1%) patients without MS. Systolic BP> 135 mmHg – 274 (75%) patients. Conclusion: All of the above results correspond to data from international studies pointing to the fact that the presence of the metabolic syndrome in patients with gout leads to organ damage, regardless of geographic location, but depends on disease duration.